Clinical Trials in Georgia

Showing 5661-5680 of 14,426 trials

Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease

NCT05074498

Part 1 of this study will be conducted to determine the safety, tolerability, and pharmacokinetic (PK) profile of multiple doses of TB006, as well as the maximum tolerated dose of TB006, and to assess the immunogenicity of TB006 (production of anti-TB006 antibody). Part 2 of this study will be conducted to determine the clinical efficacy of TB006 in participants with mild to severe Alzheimer's Disease.

Alzheimer's Disease

TrueBinding, Inc.154 participantsStarted Oct 2021

Garden Grove, California, United States • San Diego, California, United States • Delray Beach, Florida, United States +15 more locations

COMPLETEDPhase 365 miles

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

NCT02542696

An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Parkinson Disease

Sumitomo Pharma America, Inc.496 participantsStarted Aug 2015

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +67 more locations

Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Find Trials by Condition in Georgia

A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab

Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study

Long Term Follow-up of the VisAbility™ Micro Insert System for Presbyopic Patients

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

Prospective Database Registry Study of Scoliosis in Children With Cerebral Palsy

A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.

A Study of TL-925 as a Treatment for Dry Eye Disease

A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer

Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

DETEC® pH Point of Care Wound Diagnostic Test

Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)